Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040418 | SCV000064109 | benign | not specified | 2015-05-06 | criteria provided, single submitter | clinical testing | p.Pro17204Leu in exon 249 of TTN: This variant is not expected to have clinical significance because it has been identified in 1.0% (99/9780) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs72646840). |
Eurofins Ntd Llc |
RCV000040418 | SCV000114415 | benign | not specified | 2013-03-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001572698 | SCV000237353 | likely benign | not provided | 2020-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000241577 | SCV000319192 | benign | Cardiovascular phenotype | 2013-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000476235 | SCV000555374 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000040418 | SCV000597649 | likely benign | not specified | 2015-08-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000040418 | SCV000616113 | benign | not specified | 2017-05-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040418 | SCV001821477 | likely benign | not specified | 2021-08-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839645 | SCV002101124 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839646 | SCV002101126 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839647 | SCV002101127 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839644 | SCV002101128 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001572698 | SCV004564976 | benign | not provided | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001572698 | SCV005074471 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | TTN: BS1 |
Diagnostic Laboratory, |
RCV000040418 | SCV001744791 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001572698 | SCV001797463 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040418 | SCV001924592 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001572698 | SCV001966368 | likely benign | not provided | no assertion criteria provided | clinical testing |